The case for external beam treatment of early-stage prostate cancer

Urology

Volumn 55, Issue 3, 2000, Pages 301-305

  Hanks, Gerald E ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BEAM THERAPY; CANCER STAGING; EDITORIAL; GASTROINTESTINAL DISEASE; HEALTH CARE COST; HUMAN; IMPLANT; INTERMETHOD COMPARISON; MALE; MEDICAL EDUCATION; MORBIDITY; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY CONTROL; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; RETROSPECTIVE STUDY; STRESS INCONTINENCE; SURVIVAL TIME; TECHNIQUE; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; UNITED STATES; URINARY DIVERSION;

AGED; BRACHYTHERAPY; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; TREATMENT OUTCOME;

EID: 0033974826     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00561-0     Document Type: Editorial

References (21)

1. Hanks G.E., Hanlon A.L., Schultheiss T.E., et al. Dose escalation with 3D conformal treatment five year outcomes, treatment optimization, and future directions . Int J Radiat Oncol Biol Phys. 41:1998;501-510.
2. Hanks G. Progress in 3D conformal radiation treatment of prostate cancer. Acta Oncol. 38:(suppl 13):1999;69-74.
3. Pollack A., Zagars G. External beam radiotherapy for stage T1/T2 prostate cancer how does it stack up? Urology. 51:1998;258-264.
4. Kupelian P., Katcher J., Levin H., et al. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores . Cancer J Sci Am. 3:1997;78-87.
5. Shipley W., Thames H., Sandler H., et al. Radiation therapy for clinically localized prostate cancer a multi-institutional pooled analysis . JAMA. 281:1999;1558-1604.
6. Cox J., Grignon D., Kaplan R., et al. Consensus statement guidelines for PSA following radiation therapy . Int J Radiat Oncol Biol Phys. 37:1997;1035-1041.
7. Ragde H., Elgamal A., Snow P., et al. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma. Cancer. 83:1998;989-1001.
8. Hanks G., Coia L., Curry J. Patterns of care studies past, present, and future . Semin Radiat Oncol. 7:1997;97-100.
9. Hanks G. Letter to the editor. Cancer. 85:1999;1204-1205.
10. Ragde H., Blasko J., Grimm P., et al. Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma. Cancer. 80:1997;442-453.
11. Ragde H., Blasko J., Grimm P., et al. Brachytherapy for clinically localized prostate cancer results at 7 and 8-year follow-up . Semin Surg Oncol. 13:1997;438-443.
12. Talcott J., Clark J., Stark P., et al. Long-term treatment related complications of brachytherapy for early prostate cancer a survey of treated patients . Am Soc Clin Oncol Progr Proc. 18:1999;311a.
13. Hanlon A., Bruner D., Hanks G. Long term quality of life study in prostate cancer patients treated with three dimensional conformal radiation therapy bowel and bladder quality of life symptoms are similar to that of the normal population . Int J Radiat Oncol Biol Phys. 45:(suppl):1999;240. (abstract).
14. Litwin M. Health related quality of life in older men without prostate cancer. J Urol. 161:1999;1180-1184.
15. Zelefsky M., Wallner L., Ling C., et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol. 17:1999;517-522.
16. Nicolaou N., Watkins-Bruner D., Hanlon A., et al. Preservation of sexual function and quality of life in younger prostate cancer patients after definitive radiation and androgen deprivation therapy a pilot study . Am Soc Clin Oncol Progr Proc. 17:1998;323a.
17. Wurzer J., Nicolaou N., Hanlon A., et al. Long term durability of potency preservation in younger prostate cancer patients following 3D conformal radiation therapy. Int J Radiat Oncol Biol Phys. 45:(suppl):1999;169. (abstract).
18. Kuban D., el-Mahdi A., Schellhammer P. Potential benefit of improved local tumor control in patients with prostate carcinoma. Cancer. 75:1995;2373-2382.
19. Fuks Z., Leibel S.A., Wallner K.E., et al. The effect of local control on metastatic dissemination in carcinoma of the prostate long term results in patients treated with I-125 implantation . Int J Radiat Oncol Biol Phys. 21:1991;537-547.
20. Kleinerman R.A., Lieberman J.F., Li F.P. Second cancer following cancer of the male genital system in Connecticut, 1935-1982. NCI Monogr. 68:1985;139-147.
21. Osterlind A., Rorth M., Prener A. Second cancer following cancer of the male genital system in Denmark, 1943-1980. NCI Monogr. 68:1985;341-343.